Related Experiment Video
Updated: Aug 10, 2026
Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings
Published on: October 25, 2015
Fetal surgery for myelomeningocele
1Center for Fetal Diagnosis and Treatment, Children's Hospital of Philadelphia, PA 19104, USA.
Insights
Myelomeningocele, a severe birth defect, has limited progress in postnatal surgical care. Fetal intervention is being explored due to the challenges of current spina bifida treatments.
Area of Science:
- Neuroscience
- Developmental Biology
- Pediatric Surgery
Background:
- Myelomeningocele is a common and severe birth defect causing lifelong morbidity.
- Current postnatal surgical management for spina bifida has seen limited advancements.
- Postnatal care involves addressing exposed spinal cords, infection, and numerous secondary complications.
Purpose of the Study:
- To outline the rationale for investigating prenatal treatment options for myelomeningocele.
- To discuss preliminary experiences with fetal surgery for myelomeningocele in humans.
Main Methods:
- Review of the rationale behind fetal intervention for myelomeningocele.
- Discussion of early clinical experiences and outcomes of human fetal myelomeningocele surgery.
Main Results:
- Limited progress in postnatal surgical management despite technological advances.
- Growing interest and investigation into prenatal treatment strategies.
- Preliminary data from human fetal surgery are being analyzed.
Conclusions:
- Current postnatal myelomeningocele treatment has significant limitations.
- Fetal intervention presents a promising alternative for managing spina bifida.
- Further research and experience are needed to establish the efficacy of prenatal surgery.
Abstract:
Myelomeningocele is a common birth defect that is associated with significant lifelong morbidity. Despite improvements in technology and overall patient care, little progress has been made in the postnatal surgical management of the child with spina bifida. Postnatal surgery is aimed at covering the exposed spinal cord and preventing infection. Numerous interventions for ventricular shunts, tethered cord, scoliosis, incontinence, urologic complications, and extremity anomalies are frequently required. Although myelomeningocele is a nonlethal fetal anomaly, the limitations with current postnatal treatment strategies has led to extensive investigation of prenatal treatment options. This article outlines the rationale for fetal intervention and discusses the preliminary experience with human fetal myelomeningocele surgery.
